82 FR 8535 - Center for Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 16 (January 26, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 16 (January 26, 2017)
| Page Range | 8535-8537 | |
| FR Document | 2017-01739 |
[Federal Register Volume 82, Number 16 (Thursday, January 26, 2017)] [Notices] [Pages 8535-8537] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-01739] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. [[Page 8536]] The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflicts: Molecular and Cellular Hematology One. Date: February 21, 2017. Time: 2:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Anshumali Chaudhari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4124, MSC 7802, Bethesda, MD 20892, (301) 435-1210, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Long-Term Outcomes of Medically Assisted Reproduction. Date: February 21, 2017. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Clara M. Cheng, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD 20892, 301-435-1041, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cellular Aspects of Diabetes and Obesity. Date: February 22, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Wardman Park Washington DC Hotel, 2660 Woodley Road NW., Washington, DC 20008. Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, EMNR IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6182, MSC 7892, Bethesda, MD 20892, 301 435-2514, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Development of the Gabriella Miller Kids First Pediatric Data Resource Center. Date: February 22, 2017. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Allen Richon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301-379- 9351, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Interventions and Mechanisms for Addictions. Date: February 22, 2017. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Marc Boulay, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 20892, (301) 300- 6541, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Vascular and Hematology. Date: February 23, 2017. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, 301-435- 0952, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Urologic and Urogynecologist Applications. Date: February 23, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Washington National Airport, 1489 Jefferson Davis Hwy., Arlington, VA 22202. Contact Person: Ganesan Ramesh, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Room 2182, MSC 7818, Bethesda, MD 20892, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA-LM-17-001: Enhancing the Efficiency and Effectiveness of Digital Curation for Biomedical Big Data (U01). Date: February 23, 2017. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Mark Caprara, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5156, MSC 7844, Bethesda, MD 20892, 301-435- 1042, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Biological Chemistry and Macromolecular Biophysics. Date: February 23-24, 2017. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sergei Ruvinov, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 20892, 301-435-1180, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Molecular Probes. Date: February 24, 2017. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Pier 2620 Hotel Fisherman's Wharf, 2620 Jones St., San Francisco, CA 94133. Contact Person: Mary Custer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435- 1164, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowship: Surgical Sciences Biomedical Imaging and Bioengineering. Date: February 24, 2017. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Donald Scott Wright, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 20892, (301) 435-8363, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Microbiome and Related Sciences. Date: February 24, 2017. Time: 10:30 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Aiping Zhao, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Rm 2188 MSC7818, Bethesda, MD 20892-7818, (301) 435-0682, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Sleep, Stress and Cardiovascular Disease. Date: February 24, 2017. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Wind Cowles, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of [[Page 8537]] Health, 6701 Rockledge Drive , Room 3172, Bethesda, MD 20892, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 19, 2017. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-01739 Filed 1-25-17; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices 8535
english-proficiency/guidance-federal- and record of performance under described in 45 CFR 75.371 Remedies
financial-assistance-recipients-title-VI/. Federal awards when completing the for noncompliance, including
The HHS Office for Civil Rights (OCR) review of risk posed by applicants as suspension or debarment (See 2 CFR
also provides guidance on complying described in 45 CFR 75.205. parts 180 & 376 and 31 U.S.C. 3321).
with civil rights laws enforced by HHS. As required by 45 CFR part 75
Please see http://www.hhs.gov/civil- VII. Agency Contacts
Appendix XII of the Uniform Guidance,
rights/for-individuals/section-1557/ non-federal entities (NFEs) are required 1. Questions on the programmatic
index.html; and http://www.hhs.gov/ to disclose in FAPIIS any information issues may be directed to: Ms. Nancy
civil-rights/index.html. Recipients of about criminal, civil, and administrative Bill, Program Manager, Injury
FFA also have specific legal obligations proceedings, and/or affirm that there is Prevention Program, IHS, 5600 Fishers
for serving qualified individuals with no new information to provide. This Lane, Mailstop 10N14–C, Rockville, MD
disabilities. Please see http:// applies to NFEs that receive Federal 20857, Phone: (301) 443–0105, Fax:
www.hhs.gov/civil-rights/for- awards (currently active grants, (301) 443–7538, E-Mail: Nancy.Bill@
individuals/disability/index.html. cooperative agreements, and ihs.gov.
Please contact the HHS OCR for more procurement contracts) greater than 2. Questions on grants management
information about obligations and $10,000,000 for any period of time and fiscal matters may be directed to:
prohibitions under Federal civil rights during the period of performance of an Andrew Diggs, Senior Grant
laws at http://www.hhs.gov/ocr/about- award/project. Management Specialist, Division of
us/contact-us/headquarters-and- Grants Management, Indian Health
regional-addresses/index.html or call 1– Mandatory Disclosure Requirements Service, 5600 Fishers Lane, Mailstop
800–368–1019 or TDD 1–800–537–7697. As required by 2 CFR part 200 of the 09E70, Rockville, MD 20857. Phone:
Also note it is an HHS Departmental Uniform Guidance, and the HHS (301) 443–2241; or the DGM main line
goal to ensure access to quality, implementing regulations at 45 CFR part (301) 443–5204, Fax: (301) 443–0899, E-
culturally competent care, including 75, effective January 1, 2016, the IHS Mail: Andrew.Diggs@ihs.gov.
long-term services and supports, for must require a non-federal entity or an 3. Questions on systems matters may
vulnerable populations. For further applicant for a Federal award to be directed to: Paul Gettys, Grant
guidance on providing culturally and disclose, in a timely manner, in writing Systems Coordinator, 5600 Fishers
linguistically appropriate services, to the IHS or pass-through entity all Lane, Mailstop: 09E70, Rockville, MD
recipients should review the National violations of Federal criminal law 20857. Phone: (301) 443–2114; or the
Standards for Culturally and involving fraud, bribery, or gratuity DGM main line (301) 443–5204, Fax:
Linguistically Appropriate Services in violations potentially affecting the (301) 443–0899, Paul.Gettys@ihs.gov.
Health and Health Care at http:// Federal award.
minorityhealth.hhs.gov/omh/ Submission is required for all VIII. Other Information
browse.aspx?lvl=2&lvlid=53. applicants and recipients, in writing, to The Public Health Service strongly
Pursuant to 45 CFR 80.3(d), an the IHS and to the HHS Office of encourages all cooperative agreement
individual shall not be deemed Inspector General all information and contract recipients to provide a
subjected to discrimination by reason of related to violations of Federal criminal smoke-free workplace and promote the
his/her exclusion from benefits limited law involving fraud, bribery, or gratuity non-use of all tobacco products. In
by Federal law to individuals eligible violations potentially affecting the addition, Pub. L. 103–227, the Pro-
for benefits and services from the IHS. Federal award. 45 CFR 75.113. Children Act of 1994, prohibits smoking
Recipients will be required to sign the Disclosures must be sent in writing to: in certain facilities (or in some cases,
HHS–690 Assurance of Compliance any portion of the facility) in which
U.S. Department of Health and Human
form which can be obtained from the regular or routine education, library,
Services Indian Health Service,
following Web site: http://www.hhs.gov/ day care, health care, or early childhood
Division of Grants Management, Attn:
sites/default/files/forms/hhs-690.pdf, development services are provided to
Robert Tarwater, Director, 5600
and send it directly to the: U.S. children. This is consistent with the
Fishers Lane, Mail Stop: 09E70,
Department of Health and Human HHS mission to protect and advance the
Rockville, Maryland 20857, (Include
Services, Office of Civil Rights, 200 physical and mental health of the
‘‘Mandatory Grant Disclosures’’ in
Independence Ave. SW., Washington, American people.
subject line). Office: (301) 443–5204,
DC 20201.
Fax: (301) 594–0899, Email: Dated: January 13, 2017.
F. Federal Awardee Performance and Robert.Tarwater@ihs.gov; Mary Smith,
Integrity Information System (FAPIIS) AND Principal Deputy Director, Indian Health
The IHS is required to review and U.S. Department of Health and Human Service.
consider any information about the Services, Office of Inspector General, [FR Doc. 2017–01806 Filed 1–25–17; 8:45 am]
applicant that is in the Federal Awardee Attn: Mandatory Grant Disclosures, BILLING CODE 4165–16–P
Performance and Integrity Information Intake Coordinator, 330 Independence
System (FAPIIS) before making any Avenue SW., Cohen Building, Room
award in excess of the simplified 5527, Washington, DC 20201, URL: DEPARTMENT OF HEALTH AND
acquisition threshold (currently http://oig.hhs.gov/fraud/report-fraud/ HUMAN SERVICES
$150,000) over the period of index.asp, (Include ‘‘Mandatory Grant
performance. An applicant may review Disclosures’’ in subject line). Fax: National Institutes of Health
jstallworth on DSK7TPTVN1PROD with NOTICES
and comment on any information about (202) 205–0604 (Include ‘‘Mandatory
Grant Disclosures’’ in subject line) or Center for Scientific Review; Notice of
itself that a Federal awarding agency
Email: Closed Meetings
previously entered. IHS will consider
any comments by the applicant, in MandatoryGranteeDisclosures@ Pursuant to section 10(d) of the
addition to other information in FAPIIS oig.hhs.gov. Federal Advisory Committee Act, as
in making a judgment about the Failure to make required disclosures amended (5 U.S.C. App.), notice is
applicant’s integrity, business ethics, can result in any of the remedies hereby given of the following meetings.
VerDate Sep<11>2014 15:10 Jan 25, 2017 Jkt 241001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1](https://thefederalregister.org/doc/82_FR_8551/page/1.svg)
![Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices 8537
Health, 6701 Rockledge Drive , Room 3172, Extramural Affairs, National Institute on Contact Person: Michael Knecht, Ph.D.,
Bethesda, MD 20892, cowleshw@csr.nih.gov. Drug Abuse, National Institutes of Health, Scientific Review Officer, Center for
(Catalogue of Federal Domestic Assistance DHHS, 6001 Executive Blvd., Room 4245, Scientific Review, National Institutes of
Program Nos. 93.306, Comparative Medicine; Rockville, MD 20852, (301) 827–5817, Health, 6701 Rockledge Drive, Room 6176,
93.333, Clinical Research, 93.306, 93.333, mcguireso@mail.nih.gov. MSC 7892, Bethesda, MD 20892, (301) 435–
93.337, 93.393–93.396, 93.837–93.844, Name of Committee: National Institute on 1046, knechtm@csr.nih.gov.
93.846–93.878, 93.892, 93.893, National Drug Abuse Special Emphasis Panel; Name of Committee: Center for Scientific
Institutes of Health, HHS) Exploratory Studies of Smoking Cessation Review Special Emphasis Panel; Molecular
Interventions for People with Schizophrenia Mechanisms of Cell Death and Disease.
Dated: January 19, 2017.
(R21/R33). Date: February 16, 2017.
Michelle Trout, Date: February 27, 2017. Time: 2:00 p.m. to 3:30 p.m.
Program Analyst, Office of Federal Advisory Time: 12:00 p.m. to 12:45 p.m. Agenda: To review and evaluate grant
Committee Policy. Agenda: To review and evaluate grant applications.
[FR Doc. 2017–01739 Filed 1–25–17; 8:45 am] applications. Place: National Institutes of Health, 6701
BILLING CODE 4140–01–P Place: National Institutes of Health, Rockledge Drive, Bethesda, MD 20892,
Neuroscience Center, 6001 Executive (Telephone Conference Call).
Boulevard, Rockville, MD 20852, (Telephone Contact Person: Carole L. Jelsema, Ph.D.,
Conference Call). Chief and Scientific Review Administrator,
DEPARTMENT OF HEALTH AND MDCN Scientific Review Group, Center for
Contact Person: Hiromi Ono, Ph.D.,
HUMAN SERVICES Scientific Review, National Institutes of
Scientific Review Officer, Office of
Extramural Affairs, National Institute on Health, 6701 Rockledge Drive, Room 4146,
National Institutes of Health MSC 7850, Bethesda, MD 20892, (301) 435–
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room 1248, jelsemac@csr.nih.gov.
National Institute on Drug Abuse; Name of Committee: Center for Scientific
4238, MSC 9550, Bethesda, MD 20892, (301)
Notice of Closed Meetings 827–5820, hiromi.ono@nih.gov. Review Special Emphasis Panel; Member
Pursuant to section 10(d) of the (Catalogue of Federal Domestic Assistance Conflict: Innate Immune Responses.
Program Nos.: 93.279, Drug Abuse and Date: February 17, 2017.
Federal Advisory Committee Act, as Time: 2:30 p.m. to 4:00 p.m.
amended (5 U.S.C. App), notice is Addiction Research Programs, National
Institutes of Health, HHS) Agenda: To review and evaluate grant
hereby given of the following meetings. applications.
The meetings will be closed to the Dated: January 19, 2017. Place: Ritz-Carlton Hotel at Pentagon City,
public in accordance with the Natasha M. Copeland, 1250 South Hayes Street, Arlington, VA
provisions set forth in sections Program Analyst, Office of Federal Advisory 22202.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Committee Policy. Contact Person: Tina McIntyre, Ph.D.,
as amended. The grant applications and Scientific Review Officer, Center for
[FR Doc. 2017–01737 Filed 1–25–17; 8:45 am]
the discussions could disclose Scientific Review, National Institutes of
confidential trade secrets or commercial
BILLING CODE 4140–01–P Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892, 301–594–
property such as patentable material, 6375, mcintyrt@csr.nih.gov.
and personal information concerning DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance
individuals associated with the grant HUMAN SERVICES Program Nos. 93.306, Comparative Medicine;
applications, the disclosure of which 93.333, Clinical Research, 93.306, 93.333,
would constitute a clearly unwarranted National Institutes of Health 93.337, 93.393–93.396, 93.837–93.844,
invasion of personal privacy. 93.846–93.878, 93.892, 93.893, National
Name of Committee: National Institute on Center for Scientific Review; Notice of Institutes of Health, HHS)
Drug Abuse Special Emphasis Panel; Closed Meetings
Coordinating Center for the HIV/AIDS and Dated: January 19, 2017.
Pursuant to section 10(d) of the David Clary,
Substance Use Cohorts Program (U24).
Date: February 17, 2017. Federal Advisory Committee Act, as Program Analyst, Office of Federal Advisory
Time: 11:00 a.m. to 2:00 p.m. amended (5 U.S.C. App.), notice is Committee Policy.
Agenda: To review and evaluate hereby given of the following meetings. [FR Doc. 2017–01735 Filed 1–25–17; 8:45 am]
cooperative agreement applications. The meetings will be closed to the
BILLING CODE 4140–01–P
Place: National Institutes of Health, public in accordance with the
Neuroscience Center, 6001 Executive provisions set forth in sections
Boulevard, Rockville, MD 20852, (Telephone 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Conference Call). DEPARTMENT OF HEALTH AND
as amended. The grant applications and HUMAN SERVICES
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of the discussions could disclose
Extramural Affairs, National Institute on confidential trade secrets or commercial National Institutes of Health
Drug Abuse, National Institutes of Health, property such as patentable material,
DHHS, 6001 Executive Boulevard, Room and personal information concerning National Institute on Minority Health
4238, MSC 9550, Bethesda, MD 20892, (301) individuals associated with the grant and Health Disparities; Notice of
827–5820, hiromi.ono@nih.gov. applications, the disclosure of which Meeting
Name of Committee: National Institute on would constitute a clearly unwarranted
Drug Abuse Special Emphasis Panel; R13 Pursuant to section 10(d) of the
invasion of personal privacy.
Conference Grant Review. Federal Advisory Committee Act, as
Date: February 17, 2017. Name of Committee: Center for Scientific amended (5 U.S.C. App.), notice is
Time: 12:00 p.m. to 5:00 p.m. Review Special Emphasis Panel; Integrative
jstallworth on DSK7TPTVN1PROD with NOTICES
hereby given of a meeting of the
Agenda: To review and evaluate grant Nutrition and Metabolic Processes. National Advisory Council on Minority
applications. Date: February 9, 2017.
Time: 3:00 p.m. to 3:30 p.m.
Health and Health Disparities.
Place: National Institutes of Health, The meeting will be open to the
Neuroscience Center, 6001 Executive Agenda: To review and evaluate grant
Boulevard, Rockville, MD 20852, (Virtual applications. public as indicated below, with
Meeting). Place: Washington Marriott at Metro attendance limited to space available.
Contact Person: Susan O. McGuire, Ph.D., Center, 775 12th Street NW., Washington, DC Individuals who plan to attend and
Scientific Review Officer, Office of 20005. need special assistance, such as sign
VerDate Sep<11>2014 15:10 Jan 25, 2017 Jkt 241001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1](https://thefederalregister.org/doc/82_FR_8551/page/3.svg)
Document Created: 2017-01-26 00:05:06
Document Modified: 2017-01-26 00:05:06
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | February 21, 2017. | |
| FR Citation | 82 FR 8535 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR